Therapeutic Consequence of Allogeneic Mesenchymal Stem Cell for Duchenne Muscular Dystrophy- Case Study

Journal Title: International Journal of Pharmaceutical Science Invention - Year 2018, Vol 7, Issue 3

Abstract

Duchenne muscular dystrophy (DMD) is an inherited disorder caused by mutation in gene that prevents the translation of dystrophin protein, which leads to massive skeletal muscle wasting. Any form of muscular dystrophy is considered as an incurable disease yet there are occupational treatments assisting patients with locomotion strengthening and to further extend the lifespan. Thus, emerging treatment strategy is warranted to improve patients’ conditions from DMD. In the present study, we have evaluated the therapeutic outcome of human umbilical cord derived mesenchymal stem cell (hUC-MSC) in patients with DMD. In light of that, we have produced therapeutically safe (chromosomal stability, stable Immunopheotyping and mesodermal lineage differentiation ability) hUC-MSCs in our GMP compliance laboratory. Patients (24 and 27 years old) were administrated (intravenous [50X106 ] + intramuscular [50X106 ]) one single dose of hUC-MSC and followed up for 12 months. Therapeutic efficacy was measured as based on the level of creatinine phosphokinase (CK) in plasma. Both patients were highly responsive to hUC-MSC and the CK level was significantly dropped from 3 rdmonth of post transplantaton. After 12 months of post transplantation the CK level was slightly increased in both patients as compared to 6 th months. However, the level of CK level was still significantly lower than basal level. In conclusion, one single dose of hUC-MSCs treatment may not be sufficient to give better clinical outcome and also these results suggested that multi-dose of hUC-MSCs may give long term beneficial effects in patient with DMD.

Authors and Affiliations

Sellamuthu Subbannagounder, Kris See Ks, Baskar Subramani

Keywords

Related Articles

Epidemiology of Retinoblastoma in Bulgaria

Introduction. Retinoblastoma is the most common intraocular malignancy and one of the most frequent solid tumors in childhood; with an incidence of 1/15,000 – 30,000 live births. It is a tumor of infancy and early childh...

Optimization of the treatment and extraction procedures for Cetellaasiatica L. Urban.

The study is to research and apply enzyme Viscozyme supported for increase the possibility of constituents from Centellaasiatica (CA) that has biological effectiveness. The results show that the Centellaasiatica extract...

Antifungal Activity Of Coccinia Indica Extracts Against Fungal Pathogens

In recent years there has been renewed interest in screening plants for novel biologically active products particularly to combat ailments, which have defied synthetics and antibiotics. Medicinal plants offer a vast sour...

Antibacterial Activity of Some Medicinal Plants Oil Used Against Uti Causing Pathogens

Infections of the urinary tract due to microorganisms affect patients of all age groups and both sexes, and they vary in severity from an unsuspected infection to a condition of severe systemic disease. UTI are generally...

Role of Adjuvant Therapy in Osteoradionecrosis (Orn) and Bisphosphonate Induced Osteonecrosis of Jaw (Bronj)

Aim; A treatment procol with pentoxifylline(PT) and A- tocoferol combination therapy to assess the utility along with standard antimicrobial therapy in a series of cases of ORN (osteoradionecrosis) of jaw and BRONJ. Mate...

Download PDF file
  • EP ID EP401400
  • DOI -
  • Views 115
  • Downloads 0

How To Cite

Sellamuthu Subbannagounder, Kris See Ks, Baskar Subramani (2018). Therapeutic Consequence of Allogeneic Mesenchymal Stem Cell for Duchenne Muscular Dystrophy- Case Study. International Journal of Pharmaceutical Science Invention, 7(3), 4-8. https://europub.co.uk/articles/-A-401400